Global Oncology Summit: Focus on Sustainability - Enduring Recorded Webcast
This continuing education activity “Global Oncology Summit: Focus on Sustainability”, is recorded from the live webinar held on 10/28/2023.
This activity, “2023 Global Oncology Summit: Focus on Sustainability”, is a recording from a half-day hybrid conference featuring didactics, panel discussions, and abstract presentations. The expert faculty provided a comprehensive overview of the sustainable approach to establishing global oncology programs in low and middle-income countries (LMIC). They discussed the challenges and evidence-based solutions to tackle these issues.
REGISTRATION FEES:
This activity is free for all
Target Audience
- Physicians
- Nurse Practitioners/ Physician Assistants
- Nurses
- Pharmacists
- Others interested in Global Oncology
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Describe the current state of access to cancer care in LMIC
- Review Challenges to access to cancer care in LMIC
- Incorporate evidence-based strategies to establish successful global oncology programs
- Describe successful models to create sustainable global oncology programs
This educational activity features recorded videos from the live webinar titled - Global Oncology Summit: Focus on Sustainability held October 28th, 2023.
The videos are placed in the following order. Feel free to view the content that is relevant to you.
50 minutes - Session I: Infrastructure Development
00:00 - 13:30 Introduction - Jerry Radich, MD
15:00 - 41:15 Infrastructure Development in LMIC - Binay Shah, MD
41:20 - 50:58 Q&A Discussion
48 minutes - Session II: Successful Partnerships
00:00 - 18:50 Tumor Board - Binaytara Foundation's Experience - Joseph Rosales, MD
19:14 - 32:46 Approach to Successful Partnership With Local Stakeholders - Dinesh Pendharkar, MD, PhD, FASCO
33:00 - 48:14 Panel Discussion - Joseph Rosales, MD; Dinesh Pendharkar, MD, PhD, FASCO; Sarah Kutika Nyagabona, MD, MMed; Barry Pizer, MBChB, PhD, FRCPCH
56 minutes - Session III: Establishment of Diagnostic Departments
00:40 - 08:35 Establishment of Radiology - Saurabh Jha, MBBS, MRCS, MS
09:45 - 22:14 Establishment of Laboratory/Pathology - Steve Kussick, MD, PhD
23:15 - 37:20 Research Infrastructure - Edus Houston Warren, MD, PhD
37:20 - 55:49 Q&A Discussion
62 minutes - Session IV: Sustainability
02:15 - 19:45 Access to Drugs and Technology - Pat Garcia-Gonzalez, MS
21:25 - 42:27 Sustainability of Global Oncology Programs: Successful Models - Shailesh Shrikhande, MD, MS, FRCS
42:30 - 1:01:49 Panel Discussion - Pat Garcia-Gonzalez, MS; Shailesh Shrikhande, MD, MS, FRCS; Ben Li, MD; Darya Kizub, MD
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
PLANNING COMMITTEE(S)
Binay Shah, MD, MHA has no relevant financial relationships to disclose at this time.
COURSE DIRECTOR(S)
jerald radich has a financial relationship (Other) with Cepheid; financial relationship (Other) with NuProbe; financial relationship (Other) with Novartis.
SPEAKER/TOPIC PRESENTER(S)
Pat Garcia-Gonzalez, MS has a financial relationship (Other) with Pfizer.
SAURABH JHA, MBBS MRCS MS has no relevant financial relationships to disclose at this time.
Darya Kizub, MD has no relevant financial relationships to disclose at this time.
Steven Kussick, MD, PhD has no relevant financial relationships to disclose at this time.
Benjamin Li, MD, MBA has no relevant financial relationships to disclose at this time.
Sarah Nyagabona, Clinical Oncologist MD, Mmed has no relevant financial relationships to disclose at this time.
Dinesh Pendharkar, Director Sarvodaya Cancer Institute, MD Phd FASCO has no relevant financial relationships to disclose at this time.
Barry Pizer has no relevant financial relationships to disclose at this time.
Joseph Rosales, MD has no relevant financial relationships to disclose at this time.
Shailesh Shrikhande has no relevant financial relationships to disclose at this time.
Edus Warren, MD, PhD has no relevant financial relationships to disclose at this time.
MODERATOR(S)
Manisha Bhattacharya has no relevant financial relationships to disclose at this time.
Danny Milner, Jr, MD, MSc, MBA has no relevant financial relationships to disclose at this time.
Andrea Wahner Hendrickson, M.D has a financial relationship (Other) with TORL biotherapeutics; financial relationship (Other) with Prolynx; financial relationship (Other) with Oxcia.